Literature DB >> 20702783

Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen.

Kevin B Spurgers1, Tim Alefantis, Brian D Peyser, Gordon T Ruthel, Alison A Bergeron, Julie A Costantino, Sven Enterlein, Krishna P Kota, R C Dutch Boltz, M Javad Aman, Vito G Delvecchio, Sina Bavari.   

Abstract

An assessment of the total protein composition of filovirus (ebolavirus and marburgvirus) virions is currently lacking. In this study, liquid chromatography-linked tandem mass spectrometry of purified ebola and marburg virions was performed to identify associated cellular proteins. Host proteins involved in cell adhesion, cytoskeleton, cell signaling, intracellular trafficking, membrane organization, and chaperones were identified. Significant overlap exists between this data set and proteomic studies of disparate viruses, including HIV-1 and influenza A, generated in multiple cell types. However, the great majority of proteins identified here have not been previously described to be incorporated within filovirus particles. Host proteins identified by liquid chromatography-linked tandem mass spectrometry could lack biological relevance because they represent protein contaminants in the virus preparation, or because they are incorporated within virions by chance. These issues were addressed using siRNA library-mediated gene knockdown (targeting each identified virion-associated host protein), followed by filovirus infection. Knockdown of several host proteins (e.g. HSPA5 and RPL18) significantly interfered with ebolavirus and marburgvirus infection, suggesting specific and relevant virion incorporation. Notably, select siRNAs inhibited ebolavirus, but enhanced marburgvirus infection, suggesting important differences between the two viruses. The proteomic analysis presented here contributes to a greater understanding of filovirus biology and potentially identifies host factors that can be targeted for antiviral drug development.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20702783      PMCID: PMC3101857          DOI: 10.1074/mcp.M110.003418

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  76 in total

1.  Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.

Authors:  Elena Chertova; Oleg Chertov; Lori V Coren; James D Roser; Charles M Trubey; Julian W Bess; Raymond C Sowder; Eugene Barsov; Brian L Hood; Robert J Fisher; Kunio Nagashima; Thomas P Conrads; Timothy D Veenstra; Jeffrey D Lifson; David E Ott
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Budding of Marburgvirus is associated with filopodia.

Authors:  Larissa Kolesnikova; Aparna B Bohil; Richard E Cheney; Stephan Becker
Journal:  Cell Microbiol       Date:  2006-11-28       Impact factor: 3.715

3.  Antiviral activity and RNA polymerase degradation following Hsp90 inhibition in a range of negative strand viruses.

Authors:  John H Connor; Margie O McKenzie; Griffith D Parks; Douglas S Lyles
Journal:  Virology       Date:  2007-01-26       Impact factor: 3.616

4.  Protein composition of the vaccinia virus mature virion.

Authors:  Wolfgang Resch; Kim K Hixson; Ronald J Moore; Mary S Lipton; Bernard Moss
Journal:  Virology       Date:  2006-09-26       Impact factor: 3.616

5.  The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR.

Authors:  Zongdi Feng; Melissa Cerveny; Zhipeng Yan; Bin He
Journal:  J Virol       Date:  2006-10-25       Impact factor: 5.103

6.  Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP.

Authors:  Shuzo Urata; Takeshi Noda; Yoshihiro Kawaoka; Shigeru Morikawa; Hideyoshi Yokosawa; Jiro Yasuda
Journal:  J Virol       Date:  2007-02-14       Impact factor: 5.103

Review 7.  Viral proteomics.

Authors:  Karen L Maxwell; Lori Frappier
Journal:  Microbiol Mol Biol Rev       Date:  2007-06       Impact factor: 11.056

8.  Dengue virus entry into liver (HepG2) cells is independent of hsp90 and hsp70.

Authors:  Arturo Cabrera-Hernandez; Chutima Thepparit; Lukkana Suksanpaisan; Duncan R Smith
Journal:  J Med Virol       Date:  2007-04       Impact factor: 2.327

9.  Regions in Ebola virus VP24 that are important for nucleocapsid formation.

Authors:  Takeshi Noda; Peter Halfmann; Hiroshi Sagara; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2007-11-15       Impact factor: 5.226

10.  Applications for protein sequence-function evolution data: mRNA/protein expression analysis and coding SNP scoring tools.

Authors:  Paul D Thomas; Anish Kejariwal; Nan Guo; Huaiyu Mi; Michael J Campbell; Anushya Muruganujan; Betty Lazareva-Ulitsky
Journal:  Nucleic Acids Res       Date:  2006-07-01       Impact factor: 16.971

View more
  37 in total

Review 1.  Emerging targets and novel approaches to Ebola virus prophylaxis and treatment.

Authors:  Jin Huk Choi; Maria A Croyle
Journal:  BioDrugs       Date:  2013-12       Impact factor: 5.807

2.  A Proteomics Survey of Junín Virus Interactions with Human Proteins Reveals Host Factors Required for Arenavirus Replication.

Authors:  Christopher M Ziegler; Philip Eisenhauer; Jamie A Kelly; Loan N Dang; Vedran Beganovic; Emily A Bruce; Benjamin R King; David J Shirley; Marion E Weir; Bryan A Ballif; Jason Botten
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

3.  Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses.

Authors:  Anastassia V Komarova; Chantal Combredet; Laurène Meyniel-Schicklin; Manuel Chapelle; Grégory Caignard; Jean-Michel Camadro; Vincent Lotteau; Pierre-Olivier Vidalain; Frédéric Tangy
Journal:  Mol Cell Proteomics       Date:  2011-09-12       Impact factor: 5.911

4.  An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.

Authors:  Emily V Nelson; Jennifer R Pacheco; Adam J Hume; Tessa N Cressey; Laure R Deflubé; John B Ruedas; John H Connor; Hideki Ebihara; Elke Mühlberger
Journal:  Antiviral Res       Date:  2017-08-12       Impact factor: 5.970

Review 5.  Proteomics Tracing the Footsteps of Infectious Disease.

Authors:  Todd M Greco; Ileana M Cristea
Journal:  Mol Cell Proteomics       Date:  2017-02-05       Impact factor: 5.911

6.  Comparative proteomics reveal fundamental structural and functional differences between the two progeny phenotypes of a baculovirus.

Authors:  Dianhai Hou; Leike Zhang; Fei Deng; Wei Fang; Ranran Wang; Xijia Liu; Lin Guo; Simon Rayner; Xinwen Chen; Hualin Wang; Zhihong Hu
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

7.  HSPA5/Dna K may be a useful target for human disease therapies.

Authors:  Laurence Booth; Jane L Roberts; Paul Dent
Journal:  DNA Cell Biol       Date:  2015-03       Impact factor: 3.311

8.  Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.

Authors:  Marc Schweneker; Andrea S Laimbacher; Gert Zimmer; Susanne Wagner; Elisabeth M Schraner; Michael Wolferstätter; Marieken Klingenberg; Ulrike Dirmeier; Robin Steigerwald; Henning Lauterbach; Hubertus Hochrein; Paul Chaplin; Mark Suter; Jürgen Hausmann
Journal:  J Virol       Date:  2017-05-12       Impact factor: 5.103

9.  The Impact of Mass Spectrometry-Based Proteomics on Fundamental Discoveries in Virology.

Authors:  Todd M Greco; Benjamin A Diner; Ileana M Cristea
Journal:  Annu Rev Virol       Date:  2014-07-14       Impact factor: 10.431

Review 10.  Cell-based genomic screening: elucidating virus-host interactions.

Authors:  Debasis Panda; Sara Cherry
Journal:  Curr Opin Virol       Date:  2012-11-02       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.